Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection
-
* Corresponding author: Francesco M Marincola Fmarincola@mail.cc.nih.gov
Genome Biology 2007, 8:R8 doi:10.1186/gb-2007-8-1-r8